|
|||||
|
|
The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk disease |
|
| Authors: | Florence K. Keane MD Ming‐Hui Chen PhD Danjie Zhang BS Marian J. Loffredo RN Philip W. Kantoff MD Andrew A. Renshaw MD Anthony V. D'Amico MD PhD |
| Affiliation: | 1. Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts;2. Department of Statistics, University of Connecticut, Storrs, Connecticut;3. Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts;4. Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts;5. Department of Pathology, Baptist Hospital of Miami, Miami, Florida |
| Abstract: | |
| Keywords: | prostate cancer radiation therapy hormonal therapy prostate‐cancer specific mortality |